Intra-Cellular Therapies (ITCI) Sell-Off on ALKS 5461 Offers 'Strong' Buying Opportunity - SunTrust Apr 2, 2018 04:41PM
Intra-Cellular Therapies (ITCI) PT Raised to $28 at SunTrust Robinson Humphrey; 'Adding Back Bipolar Depression' Mar 2, 2018 09:03AM
UPDATE: SunTrust Robinson Humphrey Upgrades Intra-Cellular Therapies (ITCI) to Buy Nov 8, 2017 10:02AM
Intra-Cellular Therapies (ITCI) PT Raised to $22 at SunTrust Robinson Humphrey Sep 7, 2017 12:52PM
SunTrust Downgrades Intra-Cellular Therapies (ITCI) to Neutral Sep 29, 2016 06:53AM


Mar 29, 2016 11:13AM Intra-Cellular Therapies (ITCI) Named Top Pick at SunTrust Robinson Humphrey (Monday)
Sep 28, 2015 04:05PM Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Sep 28, 2015 04:05PM Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Sep 23, 2015 06:46AM Intra-Cellular Therapies (ITCI) Prices 6.9M Common Stock Offering at $43.50/Share
Sep 22, 2015 06:40PM Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
Sep 22, 2015 06:40PM Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
Sep 21, 2015 04:12PM Intra-Cellular Therapies (ITCI) to Offer $300M in Common Stock
Sep 21, 2015 04:12PM Intra-Cellular Therapies (ITCI) Commences $300M Common Stock Offering
Sep 21, 2015 04:01PM Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
May 6, 2015 06:55AM SunTrust Starts Intra-Cellular Therapies (ITCI) at Buy
Mar 11, 2015 04:01PM Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Mar 11, 2015 04:01PM Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Mar 6, 2015 06:14AM Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share
Mar 5, 2015 09:00PM Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
Mar 5, 2015 09:00PM Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock